Q: Would you recommend to buy, hold, or sell GSK?
I ask on behalf of a relative I help with investing. GSK is currently 1.3% of their portfolio. I had already been thinking of recommending that they sell when the news on June 3 came out:
"Shares of GSK dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker."
They are at a 15% loss with their GSK holding (less if you consider dividends), but luckily it is a small part of the portfolio.
I am leaning toward a 'sell recommendation' but am open to counter arguments.
Thanks so much!
I ask on behalf of a relative I help with investing. GSK is currently 1.3% of their portfolio. I had already been thinking of recommending that they sell when the news on June 3 came out:
"Shares of GSK dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker."
They are at a 15% loss with their GSK holding (less if you consider dividends), but luckily it is a small part of the portfolio.
I am leaning toward a 'sell recommendation' but am open to counter arguments.
Thanks so much!
Q: With the offer on the table and the share price having moved so close to the asking price would you sell now? Also, could you please outline the details of the offer and the pros and cons. Thank you. John
-
GSK plc American Depositary Shares (Each representing two) (GSK)
-
Haleon plc American Depositary Shares (Each representing two) (HLN)
Q: Hello, I still have some GSK shares but some are now HLN. How does a demerger affect the HLN shares and what are your thoughts about HLN? Thank you.